当前位置: X-MOL 学术BioMed Res. Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Traditional Medicinal Plants as a Source of Antituberculosis Drugs: A System Review
BioMed Research International ( IF 2.6 ) Pub Date : 2021-09-10 , DOI: 10.1155/2021/9910365
Yuhui Xu 1 , Bowen Liang 2 , Chengcheng Kong 3, 4 , Zhaogang Sun 3, 4
Affiliation  

Medicinal plants are the chief components in the different oriental formulations in different traditional medical systems worldwide. As a thriving source of medicine, the medicinal plants with antituberculosis (TB) properties inspire the pharmacists to develop new drugs based on their active components or semimetabolites. In the present review, the anti-TB medicinal plants were screened from the scientific literatures, based on the botanical classification and the anti-TB activity. The obtained anti-TB medicinal plants were categorized into three different categories, viz., 159 plants critically examined with a total 335 isolated compounds, 131 plants with their crude extracts showing anti-TB activity, and 27 plants in literature with the prescribed formula by the traditional healers. Our systemic analysis on the medicinal plants can assist the discovery of novel and more efficacious anti-TB drugs.

中文翻译:

传统药用植物作为抗结核药物的来源:系统综述

药用植物是全球不同传统医疗系统中不同东方配方的主要成分。作为一种蓬勃发展的药物来源,具有抗结核 (TB) 特性的药用植物激发了药剂师基于其活性成分或半代谢物开发新药的灵感。在本综述中,根据植物学分类和抗结核活性,从科学文献中筛选出抗结核药用植物。获得的抗结核药用植物分为三类,即。, 对 159 株植物进行严格检查,共分离出 335 种化合物,131 株植物的粗提取物显示出抗结核活性,文献中的 27 株植物具有传统治疗师的处方。我们对药用植物的系统分析可以帮助发现新的和更有效的抗结核药物。
更新日期:2021-09-10
down
wechat
bug